Acorai, a clinical-stage company pioneering non-invasive hemodynamic monitoring for heart failure management, this week ...

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

The centerpiece of Ultra V3 is the Iris router, which replaces Jupiter’s retired Metis system. According to Jupiter Exchange, ...

The test is intended for adults 55 and older in the United States who are showing signs or symptoms of cognitive decline.

Eli Lilly and Company (NYSE: LLY) today announced that new data from across its oncology portfolio and pipeline will be ...

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...

A Swedish-led study validated a self-administered digital cognitive test (BioCog) in primary care, showing it can accurately ...

AI’s real power lies not only in logistics efficiency but also in building long-term relationships with customers. Their ...